Logo image of TR1.DE

T ROWE PRICE GROUP INC (TR1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:TR1 - US74144T1088 - Common Stock

89.05 EUR
+0.5 (+0.56%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

7

Overall TR1 gets a fundamental rating of 7 out of 10. We evaluated TR1 against 117 industry peers in the Capital Markets industry. While TR1 has a great health rating, its profitability is only average at the moment. TR1 may be a bit undervalued, certainly considering the very reasonable score on growth Finally TR1 also has an excellent dividend rating. These ratings could make TR1 a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

TR1 had positive earnings in the past year.
TR1 had a positive operating cash flow in the past year.
In the past 5 years TR1 has always been profitable.
TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

TR1's Return On Assets of 13.79% is amongst the best of the industry. TR1 outperforms 94.02% of its industry peers.
With a decent Return On Equity value of 18.78%, TR1 is doing good in the industry, outperforming 77.78% of the companies in the same industry.
TR1's Return On Invested Capital of 13.51% is amongst the best of the industry. TR1 outperforms 91.45% of its industry peers.
TR1 had an Average Return On Invested Capital over the past 3 years of 15.27%. This is significantly above the industry average of 8.68%.
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROIC 13.51%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

TR1's Profit Margin of 28.18% is fine compared to the rest of the industry. TR1 outperforms 75.21% of its industry peers.
TR1's Profit Margin has declined in the last couple of years.
TR1 has a better Operating Margin (32.91%) than 73.50% of its industry peers.
In the last couple of years the Operating Margin of TR1 has declined.
Industry RankSector Rank
OM 32.91%
PM (TTM) 28.18%
GM N/A
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The number of shares outstanding for TR1 has been reduced compared to 1 year ago.
Compared to 5 years ago, TR1 has less shares outstanding
TR1 has a better debt/assets ratio than last year.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

TR1 has an Altman-Z score of 5.78. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.78, TR1 belongs to the top of the industry, outperforming 93.16% of the companies in the same industry.
TR1 has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
TR1's Debt to FCF ratio of 0.03 is amongst the best of the industry. TR1 outperforms 98.29% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that TR1 is not too dependend on debt financing.
TR1 has a better Debt to Equity ratio (0.00) than 90.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 5.78
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

TR1 has a Current Ratio of 2.76. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of TR1 (2.76) is better than 88.03% of its industry peers.
A Quick Ratio of 2.76 indicates that TR1 has no problem at all paying its short term obligations.
The Quick ratio of TR1 (2.76) is better than 88.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.76
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.26% over the past year.
TR1 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.42% yearly.
Looking at the last year, TR1 shows a small growth in Revenue. The Revenue has grown by 4.26% in the last year.
The Revenue has been growing slightly by 4.78% on average over the past years.
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%

3.2 Future

Based on estimates for the next years, TR1 will show a small growth in Earnings Per Share. The EPS will grow by 4.23% on average per year.
Based on estimates for the next years, TR1 will show a small growth in Revenue. The Revenue will grow by 1.47% on average per year.
EPS Next Y6.35%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
EPS Next 5Y4.23%
Revenue Next Year2.74%
Revenue Next 2Y4.16%
Revenue Next 3Y3.44%
Revenue Next 5Y1.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.13 indicates a reasonable valuation of TR1.
82.91% of the companies in the same industry are more expensive than TR1, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of TR1 to the average of the S&P500 Index (26.51), we can say TR1 is valued rather cheaply.
TR1 is valuated reasonably with a Price/Forward Earnings ratio of 10.01.
Based on the Price/Forward Earnings ratio, TR1 is valued cheaper than 89.74% of the companies in the same industry.
TR1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.13.
Industry RankSector Rank
PE 11.13
Fwd PE 10.01
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

TR1's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TR1 is cheaper than 84.62% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TR1 is valued a bit cheaper than the industry average as 74.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.52
EV/EBITDA 7.27
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
TR1 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.75
PEG (5Y)4.61
EPS Next 2Y5.83%
EPS Next 3Y3.92%

7

5. Dividend

5.1 Amount

TR1 has a Yearly Dividend Yield of 4.85%, which is a nice return.
Compared to an average industry Dividend Yield of 3.29, TR1 pays a better dividend. On top of this TR1 pays more dividend than 80.34% of the companies listed in the same industry.
TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 4.85%

5.2 History

The dividend of TR1 is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

56.29% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP56.29%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

T ROWE PRICE GROUP INC

FRA:TR1 (12/29/2025, 7:00:00 PM)

89.05

+0.5 (+0.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners81.36%
Inst Owner ChangeN/A
Ins Owners1.66%
Ins Owner ChangeN/A
Market Cap19.43B
Revenue(TTM)7.21B
Net Income(TTM)2.03B
Analysts49.47
Price Target95.49 (7.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.85%
Yearly Dividend4.31
Dividend Growth(5Y)10.37%
DP56.29%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.28%
Min EPS beat(2)2.88%
Max EPS beat(2)9.67%
EPS beat(4)3
Avg EPS beat(4)2.48%
Min EPS beat(4)-5.31%
Max EPS beat(4)9.67%
EPS beat(8)6
Avg EPS beat(8)4.37%
EPS beat(12)10
Avg EPS beat(12)5.89%
EPS beat(16)11
Avg EPS beat(16)2.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.2%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-2.66%
Min Revenue beat(4)-4.33%
Max Revenue beat(4)-1.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.88%
Revenue beat(12)2
Avg Revenue beat(12)-2.22%
Revenue beat(16)3
Avg Revenue beat(16)-2.74%
PT rev (1m)-1.8%
PT rev (3m)6%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)6.81%
EPS NY rev (1m)2.7%
EPS NY rev (3m)5.79%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)2.99%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)1.48%
Valuation
Industry RankSector Rank
PE 11.13
Fwd PE 10.01
P/S 3.17
P/FCF 19.52
P/OCF 15.32
P/B 2.11
P/tB 2.9
EV/EBITDA 7.27
EPS(TTM)8
EY8.98%
EPS(NY)8.89
Fwd EY9.99%
FCF(TTM)4.56
FCFY5.12%
OCF(TTM)5.81
OCFY6.53%
SpS28.1
BVpS42.17
TBVpS30.72
PEG (NY)1.75
PEG (5Y)4.61
Graham Number87.13
Profitability
Industry RankSector Rank
ROA 13.79%
ROE 18.78%
ROCE 18.12%
ROIC 13.51%
ROICexc 18.68%
ROICexgc 30.26%
OM 32.91%
PM (TTM) 28.18%
GM N/A
FCFM 16.23%
ROA(3y)14.15%
ROA(5y)17.62%
ROE(3y)18.44%
ROE(5y)23.71%
ROIC(3y)15.27%
ROIC(5y)18%
ROICexc(3y)18.71%
ROICexc(5y)21.89%
ROICexgc(3y)30.22%
ROICexgc(5y)33.06%
ROCE(3y)20.58%
ROCE(5y)24.24%
ROICexgc growth 3Y-16.2%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-13.37%
ROICexc growth 5Y-6.73%
OM growth 3Y-11.5%
OM growth 5Y-4.63%
PM growth 3Y-9.7%
PM growth 5Y-4.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA 0.01
Cap/Depr 118.97%
Cap/Sales 4.45%
Interest Coverage 250
Cash Conversion 56.43%
Profit Quality 57.6%
Current Ratio 2.76
Quick Ratio 2.76
Altman-Z 5.78
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)130.91%
Cap/Depr(5y)124.54%
Cap/Sales(3y)4.8%
Cap/Sales(5y)4.19%
Profit Quality(3y)84.47%
Profit Quality(5y)86.86%
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-9.91%
EPS 5Y2.42%
EPS Q2Q%9.34%
EPS Next Y6.35%
EPS Next 2Y5.83%
EPS Next 3Y3.92%
EPS Next 5Y4.23%
Revenue 1Y (TTM)4.26%
Revenue growth 3Y-2.58%
Revenue growth 5Y4.78%
Sales Q2Q%6.04%
Revenue Next Year2.74%
Revenue Next 2Y4.16%
Revenue Next 3Y3.44%
Revenue Next 5Y1.47%
EBIT growth 1Y7.98%
EBIT growth 3Y-13.78%
EBIT growth 5Y-0.07%
EBIT Next Year7.84%
EBIT Next 3Y6.45%
EBIT Next 5Y0.98%
FCF growth 1Y22.49%
FCF growth 3Y-26.76%
FCF growth 5Y-0.86%
OCF growth 1Y20.05%
OCF growth 3Y-21.25%
OCF growth 5Y2.05%

T ROWE PRICE GROUP INC / TR1.DE FAQ

Can you provide the ChartMill fundamental rating for T ROWE PRICE GROUP INC?

ChartMill assigns a fundamental rating of 7 / 10 to TR1.DE.


What is the valuation status of T ROWE PRICE GROUP INC (TR1.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to T ROWE PRICE GROUP INC (TR1.DE). This can be considered as Undervalued.


Can you provide the profitability details for T ROWE PRICE GROUP INC?

T ROWE PRICE GROUP INC (TR1.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for TR1 stock?

The financial health rating of T ROWE PRICE GROUP INC (TR1.DE) is 9 / 10.


What is the expected EPS growth for T ROWE PRICE GROUP INC (TR1.DE) stock?

The Earnings per Share (EPS) of T ROWE PRICE GROUP INC (TR1.DE) is expected to grow by 6.35% in the next year.